JPRN-UMIN000002423招募中未知
Assessment of pleiotropic and proteinuria reducing effect of irbesartan in chronic kidney disease patients - Pleiotropic effect of irbesartan in chronic kidney disease patients
Division of Nephrology Department of Medicine, Showa University School of Medicine0 个研究点目标入组 20 人开始时间: 2009年9月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients who has past history of adverse effect of taking another ARB 2) Pregnancy 3) Patients who has serious liver disease and coronary heart disease or nephrotic syndrome 4) Judged inappropriate for this study by the physicians
研究者
相似试验
已完成
不适用
Assessment of pleiotropic and proteinuria reducing effect of irbesartan and losartan in chronic kidney disease patientsChronic kidney disease stage 1-4JPRN-UMIN000002424Division of Nephrology Department of Medicine, Showa University School of Medicine20
已完成
不适用
Clinical significance of proteinuria without hypertension during pregnancyPreeclampsiaJPRN-UMIN000006925Department of Obstetrics, Reproductive and Developmental Medicine, Division of Pathophysiological Science, Hokkaido University Graduate School of Medicine150
招募中
1 期
Clinical observation on treatment of proteinuria in stage i-ii of chronic kidney disease by acupoint selection based on syndrome differentiation combined with classical prescriptionsITMCTR2100004883Heilongjiangl Academy of Traditional Chinese Medicine
终止
4 期
Anti-Proteinuric Response to ACEI, ARB and Diuretics Combination.Heavy ProteinuriaNCT00200694Nantes University Hospital18
已完成
1 期
Safety and Pharmacokinetic Study of Subcutaneous ALXN1720 in Participants With ProteinuriaProteinuriaNCT05314231Alexion Pharmaceuticals, Inc.13